Abstract
Introduction
The aim of the study was to describe the levels of circulating monocyte/macrophage pro-inflammatory cytokines (TNF-α, IL-1β IL-6, and IL-8) and an anti-inflammatory cytokine (IL-10) in inflammatory bowel disease (IBD) and colorectal cancer (CRC) patients and healthy controls.
Materials and Methods
The study was conducted on 15 healthy individuals, 20 patients with ulcerative colitis (UC), 12 with Crohn’s disease (CD), and 15 with CRC (Dukes’ stage B). Blood serum cytokine levels were measured by ELISA.
Results
The patients with UC had significantly higher levels of the pro-inflammatory cytokines and of circulating IL-10 than the healthy controls. The patients with CD and CRC had the same specific pattern of serum cytokines of significantly elevated levels of the pro-inflammatory cytokines, but the IL-10 levels were within the range found in the healthy individuals.
Conclusions
Thus our results demonstrate that both IBD and CRC are linked with an intensified production of a wide array of monocyte/macrophage pro-inflammatory cytokines which is not accompanied by elevated levels of circulating IL-10, except for its insufficiently inhibitory elevation in UC patients.
Article PDF
Similar content being viewed by others
References
Askling J, Dickman PW, Karlen P et al (2001) Colorectal cancer rates among first-degree relatives of patients with inflammatory bowel disease: a population-based cohort study. Lancet 357: 262–266
Autschbach F, Giese T, Gassler N et al (2002) Cytokine/chemokine messenger-RNA expression profiles in ulcerative colitis and Crohn’s disease. Virchows Arch 441: 500–513
Belluco C, Nitti D, Frantz M et al (2000) Interleukin-6 blood levels is associated with circulating carcinoembryonic antigen and prognosis in patients with colorectal cancer. Ann Surg Oncol 7: 133–138
Best WR, Becktel JM, Singleton JW et al (1976) Development of a Crohn’s disease activity index. Gastroenterology 70: 439–444
Bull TJ, McMinn EJ, Sidi-Boumedine K et al (2003) Detection and verification of Mycobacterium avium subsp. paratuberculosis in fresh ileocolonic mucosal biopsy specimens from individuals with and without Crohn’s disease. J Clin Microbiol 41: 2915–2923
Eaden JA, Abrams KR, Mayberry JF (2001) The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut 48: 526–535
Fujino S, Andoh A, Bamba S et al (2003) Increased expression of interleukin 17 in inflammatory bowel disease. Gut 52: 65–70
Fuss IJ, Heller F, Boirivant M et al (2004) Nonclassical CD1d-restricted NK T cells that produce IL-13 characterize an atypical Th2 response in ulcerative colitis. J Clin Invest 113: 1490–1497
Galizia G, Orditura M, Romano C et al (2002) Prognostic significance of circulating IL-10 and IL-6 serum levels in colon cancer patients undergoing surgery. Clin Immunol 102: 169–178
Geboes K, Riddell R, Öst A et al (2000) A reproducible grading scale for histological assessment of inflammation in ulcerative colitis. Gut 47: 404–409
Groux H, O’Garra A, Bigler M et al (1997) A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 389: 737–742
Hyun JG, Mayer L (2006) Mechanisms underlying inflammatory bowel disease. Drug Discov Today Dis Mech 3: 457–462
Jess T, Gamborg M, Matzen P et al (2005) Increased risk of intestinal cancer in Crohn’s disease: a meta-analysis of population- based cohort studies. Am J Gastroenterol 100: 2724–2729
Kamińska J, Kowalska MM, Nowacki MP et al (2000) CRP, TNF-a, IL-1ra, IL-6, IL-8 and IL-10 in blood serum of colorectal cancer patients. Pathol Oncol Res 6: 38–41
Li MC, He SH (2004) IL-10 and its related cytokines for treatment of inflammatory bowel disease. World J Gastroenterol 10: 620–625
Medzhitov R, Janeway CA (1997) Innate immunity: impact on the adaptive immune response. Curr Opin Immunol 9: 4–9
Mosmann TR, Sad S (1996) The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol Today 17: 138–146
Oppenheim JJ, Neta R (1994) Pathophysiological roles of cytokines in development, immunity and inflammation. FASEB J 8: 158–162
Pestka S, Krause CD, Sarkar D et al (2004) Interleukin-10 and related cytokines and receptors. Annu Rev Immunol 22: 929–979
Plevy SE, Landers CJ, Prehn J (1997) A role for TNF-alpha and mucosal T helper-1 cytokines in the pathogenesis of Crohn’s disease. J Immunol 159: 6276–6282
Rennick DM, Fort MM (2000) Lessons from genetically engineered animal models. XII. IL-10-deficient (IL-10-/-) mice and intestinal inflammation. Am J Physiol Gastrointest Liver Physiol 278: G829–833
Rogler G, Andus T (1998) Cytokines in inflammatory bowel disease. World J Surg 22: 382–389
Sartor RB (2004) Therapeutic manipulation of the enteric microflora in inflammatory bowel disease: antibiotics, probiotics, and prebiotics. Gastroenterology 126: 1620–1633
Shih DQ, Targan SR (2008) Immunopathogenesis of inflammatory bowel disease. World J Gastroenterol 14: 390–400
Szkaradkiewicz A, Chudzicka-Strugala I, Zwozdziak B (2007) Mycobacterium avium subsp. paratuberculosis in inflammatory bowel diseases. Przegl Epidemiol 61: 85–90
Taylor A, Verhagen J, Blaser K et al (2006) Mechanisms of immune suppression by interleukin-10 and transforming growth factor-β the role of T regulatory cells. Immunology 117: 433–442
Wiercińska-Drapało A, Flisiak R, Prokopowicz D (2001) Effect of ulcerative colitis activity on plasma concentration of transforming growth factor beta1. Cytokine 14: 343–346
Yen D, Cheung J, Scheerens H et al (2006) IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL- 17 and IL-6. J Clin Invest 116: 1310–1316
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
This article is published under an open access license. Please check the 'Copyright Information' section either on this page or in the PDF for details of this license and what re-use is permitted. If your intended use exceeds what is permitted by the license or if you are unable to locate the licence and re-use information, please contact the Rights and Permissions team.
About this article
Cite this article
Szkaradkiewicz, A., Marciniak, R., Chudzicka-Strugała, I. et al. Proinflammatory cytokines and IL-10 in inflammatory bowel disease and colorectal cancer patients. Arch. Immunol. Ther. Exp. 57, 291–294 (2009). https://doi.org/10.1007/s00005-009-0031-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00005-009-0031-z